Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 113.00
-2.50 (-2.16%)
Mar 4, 2026, 10:33 AM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 3.13 billion as of March 3, 2026. Its market cap has decreased by -6.10% in one year.
Market Cap
3.13B
Enterprise Value
3.08B
Revenue
2.14B
Ranking
n/a
PE Ratio
11.54
Stock Price
113.00
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.13B, an increase of 741.44%. That is a compound annual growth rate of 10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.13B | -0.43% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 3.77B |
| BRIM Biotechnology | 3.58B |
| Sagittarius Life Science | 3.49B |
| Shine-On BioMedical | 3.40B |
| SYN-TECH Chem. & Pharm. | 3.23B |
| 3D Global Biotech | 3.07B |
| Apex Biotechnology | 2.99B |
| GlycoNex Incorporation | 2.68B |